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ABSTRACT 
BACKGROUND: Acute renal failure (ARF) is a clinical syndrome characterised by a 
rapid deterioration of kidney function over hours to days which may recover/return to 
normal values following appropriate therapy. Various scoring systems currently exist 
to predict the severity and outcome in patients with ARF. Recently the Acute Dialysis 
Quality Initiative (ADQI) Group has established the RIFLE (Risk of injury, Injury to 
the kidney, Failure of kidney function, Loss of kidney function, and End-stage kidney 
disease) classification which has become widely used globally. There is however, 
limited data on its use in Africa. 
In order to provide data on the use of RIFLE criteria from an African facility, we 
conducted a retrospective chart review to assess the outcome of ARF in patients 
admitted in the Intensive Care Unit (ICU) at Charlotte Maxeke Johannesburg 
Academic Hospital (CMJAH). The data reviewed covered the period between 
January 1st to December 31st 2008. 
METHODS: This was a retrospective chart review conducted in the adult multi-
disciplinary intensive care unit at CMJAH between January 1st to December 31st 
2008. Medical records of patients admitted during this period were reviewed and 
patients with acute renal failure were identified. Demographic data, relevant clinical 
information such as reason for ICU admission, number of organ(s) involved, 
presence of co-morbidity, RIFLE criteria on admission and on discharge, modality 
and duration of treatment of ARF, need for mechanical ventilation and or inotropic 
support were recorded. For the purpose of this study, serum creatinine based on 
RIFLE classification was used to define ARF. Statistical analysis was performed 
using the data collected and STATA version 11. The Primary outcome, which was 
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survival or death, was correlated with the maximum RIFLE classification during 
patients’ ICU stay. The study was approved by the Human Research Ethics 
Committee medical (HRECM) of the University of Witwatersrand with Clearance 
certificate number M090906 
RESULTS: One hundred and ninety three (193) patients with acute renal failure 
were included in the study. The mean APACHE II score was 19 ± 6.4 SD, with the 
maximum score documented being 38. Patient ages ranged from 21 – 92 years with 
a mean of 50.5 years ± 18.3SD. Fifty two percent of the patients were male and 48% 
were female. Majority of patients were black (63%) with 36.8% being other race 
groups. 
According to RIFLE criteria on admission, 40.9% had normal renal function, 23.3%, 
14.0% and 21.8% were in RIFLE R, I and F classes respectively. The overall 
mortality in ICU was 59.9%. Of those patients discharged to the ward from ICU, 
14.1% subsequently demised. Factors associated with mortality in ICU included 
race, chronic pulmonary disease, mechanical ventilation, inotropic support, need for 
ventilation and inotropic support, dialysis and maximum RIFLE criteria reached in 
ICU. After multivariate analysis using Cox proportion regression model, factors such 
as race, inotropic support, need for both ventilation and inotropic support and 
maximum RIFLE criteria were independently associated with mortality in ICU, 
whereas for patients discharged from ICU to the ward, only cancer was found to be 
independently associated with mortality. Based on RIFLE criteria, patients in R, I, 
and F class had 5.41, 3.17 and 5.69 greater risk of dying respectively as compared 
to patients with normal renal function (Adjusted HR 5.41 95%CI 2.66 - 11.0, p-Value 
0.000 for R class, HR 3.17 95%CI 1.65 - 6.07, p-value 0.001for I class, and HR 5.69 
95%CI 2.93 - 11.06, p-value 0.001 for F class) 
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CONCLUSION: RIFLE criteria is a useful tool for predicting the outcome of acute 
renal failure in the intensive care unit. 
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CHAPTER ONE 
1. INTRODUCTION AND BACKGROUND 
Acute renal failure (ARF) is a clinical syndrome characterised by a rapid deterioration 
of kidney function over hours to days which may recover/return to normal value 
following appropriate therapy. 
It is serious common complication in critically ill patients and is associated with high 
morbidity and mortality (1).Depending on the exact definition used, the incidence and 
prevalence of ARF in the intensive care unit (ICU) has been reported to be between 
11% and 67% (1,2,3,8). It is usually asymptomatic and nonspecific but depending on 
the severity may present with various complications such as a metabolic acidosis, 
uraemia with its associated complications, electrolyte and fluid balance disturbance, 
and multiple organ dysfunction.  
The pathophysiological mechanism of acute renal failure in a critically ill patient 
differs depending on the causative/precipitating agents, but some generally accepted 
concepts include, metabolic derangement which is exacerbated in ARF and results 
in loss of renal homeostatic function. Once established this further stimulates several 
inflammatory cytokines (4) and ischaemic and toxic insults to the kidney result in a 
cascade of events (5), (figures 1 and 2). 
Based on the mechanism and predisposing factors involved and or timing of 
appropriate management, the renal recovery may be complete (kidney function 
returns to baseline), partial (a persistent change but not persistent need for renal 
replacement therapy, (RRT)) (9) or RRT independent at ICU and hospital discharge 
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(16) or progression to chronic renal disease as demonstrated in figure1 (4) and 
figure 3 (11). 
 
Figure 1: Proposed mechanism for dysmetabolism of AKI (AKI-acute kidney injury, 
MOSF-multiple organ systemic failure). Adapted from Himmelfarb J, Ikizler TA. 
Kidney International 2007; 71: 971–976. 
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. 
 
Figure 2.Pathogenesis of ischemic ARF. Adapted from Schrier RW et al, J Clin. 
Invest. 2004; 114:5-14 
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Figure 3.Natural history of ARF. Reproduced from Cerda J et al, Clin J Am Soc 
Nephrol 2008; 3: 881-886.  
ARF is diagnosed on the basis of clinical presentation such as general patient’s 
state, decreased urine production complimented with laboratory results and renal 
imaging. Urine output and characteristic laboratory findings have been used as the 
main parameters in defining and classifying ARF patients in ICU and hospital set up 
(9, 19,21). 
1.1. SCORING SYSTEM. 
Several scoring systems aimed at predicting risk of mortality and evaluating outcome 
in critically ill patients have been published and are in practice (10). Some of these 
scoring systems have no joint reference points and this has led to many definitions of 
Acute Renal Failure being used, which in turn has created confusion (9). Bellomo et 
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al. (2001) proposed a criteria derived from the acute lung injury/acute respiratory 
distress syndrome criteria to categorize different presentations of acute renal failure 
into three classified stages namely acute renal injury (ARI), acute renal failure 
syndrome (ARFS) and severe acute renal failure syndrome (SARF) based on 
absolute values of serum urea and serum creatinine, or urine output and the need for 
renal replacement therapy (Table 1) (21). Despite the fact that these criteria were not 
widely used, they became the foundation of the existing scoring systems. Recently 
the RIFLE classification (RIFLE stands for Risk of kidney injury, Injury to the kidney, 
Failure of kidney function, Loss of kidney functions, End-stage kidney disease) was 
established by Acute Dialysis Quality Initiative (ADQI) Group as represented in 
Figure 4 (9). 
Table 1. Proposed criteria for ARI, ARFS, and SARFS. 
ARI ARFS SARFS 
Creat >120µmol/l and Urea 
>8mmol/l and/ or UO 
<800ml/24h or UO <200ml/6h 
Creat >240µmol/l and Urea 
>16mmol/l and/or <400ml/24h 
or UO <100ml/6h 
Need for RRT 
and either ARI or 
ARFS 
If A/C ARI use increase in 
Creat of 60µmol/l or in urea of 
4mmol/l and or UO same as 
above 
If A/C ARI use increase in Creat 
of 1200µmol/l or in urea of 
8mmol/l and or UO same as 
above 
Need for RRT 
and A/C criteria 
for ARI or ARFS 
 
ARI-Acute Renal Injury, ARFS-Acute Renal Failure Syndrome, SARFS-Severe Acute 
Renal Failure Syndrome, RRT-Renal Replacement Therapy, UO-Urine Output 
Adapted from Bellomo R et al, Intensive Care Med 2001; 27:1685-8 
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Figure 4: Classification for ARF using RIFLE criteria (acronyms for Risk of kidney 
injury, Injury to the kidney, Failure of kidney functions, Loss for kidney functions and 
End-stage kidney disease). Reproduced from Bellomo R et al, Critical care 
2004;8:R204-12. 
 
RIFLE classification evaluates various parameters as elucidated above and is now 
regarded as a useful tool for predicting mortality (5, 6, 7, 8, 26, 33) and outcome in 
ARF patients in ICU (6).Currently, AKIN (Acute Kidney Injury Network) has proposed 
a modification of RIFLE criteria into AKI staging system(19,20)as shown in Table 2. 
In both classifications each class increases with increase in severity but they differ in 
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their level of predicting outcome. Limited data exists with the use of these 
classifications in African ICU’s. 
Table 2: Classification/staging system for acute kidney injury (AKI). 
AKI stage Creatinine criteria Urine output criteria 
AKI stage 
I 
Increase of serum creatinine by 
≥ 0.3 mg/dl (≥ 26.4 μmol/L) 
or 
increase to ≥ 150% – 200% from 
baseline 
 
Urine output < 0.5 ml/kg/hour for 
> 6 hours 
 
AKI stage 
II 
Increase of serum creatinine to 
> 200% – 300% from baseline 
Urine output < 0.5 ml/kg/hour for 
> 6 hours 
AKI stage 
III 
Increase of serum creatinine to 
> 300% from baseline 
or 
serum creatinine ≥ 4.0 mg/dl 
(≥ 354 μmol/L) after a rise of at least 
44 μmol/L 
or 
treatment with renal replacement 
therapy 
 
Urine output < 0.3 ml/kg/hour for 
> 24 hours 
or 
anuria for 12 hours 
 
Reproduced from Ostermann M et al, Crit Care 2008; 12(6): R144.  
 
1.2. Statement of the problem and Justification 
The mortality of patients with acute renal failure in intensive care unit irrespective of 
cause is considerable worldwide. Early detection of any renal function derangement 
and prompt initiation of appropriate management plays a significant role in altering 
the outcome of acute renal failure in critically ill patients. The delay in immediate 
management of patients with acute renal failure in the intensive care set up results in 
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potentially serious complications which further contribute to high morbidity and 
mortality (37, 38, 39). In order to address the above problem, various scoring 
systems such as RIFLE criteria and the AKIN staging system have been developed 
in an effort to improve the ability to predict the outcome of ARF patients in ICU. 
Despite the fact that both systems have been shown to predict hospital mortality and 
short-term prognosis, the RIFLE criteria has better discriminatory power and overall 
correctness than the AKIN criteria (21).The use of RIFLE criteria has not been 
documented in African ICUs’ despite evidence that it represents a simple and useful 
tool for early ARF detection and prediction of its outcome in ICU and hospitals (18). 
This study therefore aims at assessing the outcome of ARF in patients admitted to 
an adult multidisciplinary ICU using the RIFLE classification. Given the above, it was 
deemed important to conduct this study using RIFLE criteria to determine the 
outcome of AKI in order to provide updated data from an academic African 
institution. A recent study at the same facility defined ARF as a rise in serum 
creatinine of more than twice the upper limit of normal (i.e.240µmol/l), and 
documented mortality rate in patients with ARF of 52.5% (24). 
It is hoped that the findings from this study will assist with future guidelines relating to 
the management of patients with ARF in ICU settings, particularly in developing 
countries. 
1.3. Literature Review 
A study from Belgium looking at predictive factors, incidence, comorbidity and 
outcome of ARF in patients with sepsis in a surgical ICU revealed that ARF 
developed in 16.2% of the patients admitted, among which 70.0% required dialysis. 
Advanced age, use of vasoactive therapy, mechanical ventilation and RRT were 
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associated with high mortality. Patients with ARF had higher mortality compared with 
patients without ARF (14). 
Data from a multinational, multicenter prospective study involving 16 countries in 
Europe reported ARF to have occurred in 24.7% of 1411 patients. The identified risk 
factors for the development of ARF were older age (more than 65 years), acute 
circulatory or respiratory failure, presence of infection, past history of chronic heart 
failure, haematological malignancy, or cirrhosis. These factors at admission were 
also associated with increased ICU mortality. The mortality rate was higher in 
patients with ARF (42.8%) than in patients without ARF (14%) (31). Patients with 
ARF might have been underreported in this study since a cut-off creatinine of greater 
than 300µmol/l was used to define ARF. 
A multicentre prospective study to assess prognostic factors in patients with acute 
renal failure due to sepsis in France revealed overall mortality of 74.5%. Factors 
associated with high mortality from this study included altered previous health status, 
previous hospital admission, need for mechanical ventilation, advanced age and 
sepsis. Mortality was much higher in elderly and septic patients with ARF (12). 
Studies from Australian Intensive Care Units have demonstrated different incidences 
of ARF. A study conducted in more than 20 ICU’s over 10 year period revealed that 
acute kidney injury occurred in a total number of 4,754 patients at the time of or 
within 24 hours of ICU admission. The  incidence in this study population ranged 
from 4.6 to 6.9% with an estimated crude cumulative incidence of 5.2%(2).This is  
similar to that found from a multinational multicenter study which revealed that 5.7% 
of patients developed ARF during their ICU stay, with a period prevalence of 1.4% to 
25% across all the study centers (1).A high incidence has been reported from the 
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same area (Australia) as demonstrated by data collected from Australia New 
Zealand Intensive Care Society Adult Patient Database (ANZICSAPD) between 
January 2000 to December 2005. One hundred and twenty thousand one hundred 
and twenty three patients were evaluated with an acute kidney injury occurring in 
36.1% within 24 h of ICU admission. Maximum RIFLE category Risk occurred in 
16.2% of the patients, Injury in 13.6% and Failure in 6.3%. The likelihood of 
developing AKI was higher in older patients (age≥65 years), females and those with 
co-morbid disease (18).  
Similar incidences have also been reported in Europe, Latin America, Asia, and the 
USA. A study in the UK and Germany involving 22,303 patients revealed that 35.4% 
to have AKI based on the AKI criteria. Of AKI patients, AKI stage I and II (same as 
RIFLE- R and I class) contributed 19.1% and 3.8% respectively and 12.5% AKI III. 
Twenty four percent of patients with AKI III had three or more organ failures as 
compared to 3.4% for AKI I and 6.4% for AKI II (19). 
A study in Brazil, which included patients of all age groups, aimed at examining 
acute kidney injury after trauma. One hundred and twenty nine patients were 
included in the study. AKI was reported to have occurred in 40.3% of the studied 
patients (25). In another study from the same area with 381 ICU admissions, ARF 
occurred in 33.5% of patients. The main causes of ARF were shown to be 
hypotension (48.4%), sepsis (40.6%), nephrotoxic drugs (21.9%), rhabdomyolysis 
(9.1%), hepatorenal syndrome (3.9%), vasculitis (3.1%), and glomerulonephritis 
(1.6%). Co-morbidities reported included respiratory insufficiency (28.9%), 
cardiovascular disease (25.8%), hypertension (19.4%) and diabetes mellitus. 
Surgical complications contributed 9.4%, liver diseases 7.8% and malignancies 
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5.3%. Independent risk factors for death included need for mechanical ventilation, 
liver failure, use of vasopressors and sepsis. The mortality rate in this population was 
found to be 62.5% (26). 
Data from a study conducted in Korea to evaluate the occurrence of AKI using 
RILFE classification in the intensive care unit showed that AKI occurred in 41.3% of 
patients with maximum RIFLE-R, I and F class in 13.8%, 12.4%, and 15.1% 
respectively. The mean age (62.5 ± 15.9 years), occurrence of AKI, pulmonary 
disease and malignancy were independent risk factors for hospital mortality. The 
overall mortality rate of ICU patients was 25.7% (27). 
A multicentre study from the USA which evaluated a total number of 5,383 patients 
has also reported that AKI developed in 67% of ICU admissions, with maximum 
RIFLE class R, I and F in 12%, 27%, and 28% respectively. The progression of 
severity from one class to the other was also noted and patients with maximum 
RIFLE class R, I and F had hospital mortality of 8.8%, 11.4% and 26.3% respectively 
(8) 
A study in patients with major burns in Sweden (n=127) has shown that 24% of 
patients with major burns as defined by total body surface area (TBSA) ≥ 20% , 
developed AKI during their study period. In this study it was also reported that half of 
the patients who developed AKI (55%, 17 of 31) reached the level for Risk within the 
first 7 days, and 81% (25 of 31) within 14 days. All patients that developed AKI had 
systemic inflammatory response syndrome (SIRS) on day one and 87% of those 
were found to have sepsis within a week before reaching RIFLE- R class. Thirty nine 
percent of patients with AKI were on nephrotoxic antibiotics and in half of these 
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patients the derangement of renal function was noted after starting these agents 
(13). 
Data from Canada in a large ICU study showed that 240 patients (4.2%of patient 
cohort) were diagnosed to have ARF and that the rate of ARF was higher in males 
and in those with age above 65 years. Risk factors for development of ARF were 
previous heart disease, stroke, pulmonary disease, diabetes mellitus, cancer, 
connective tissue disease and alcoholism (16). The recovery rate of  renal function  
in ARF survivors at ICU and hospital discharge in this and other studies has been 
shown  to range between 38% and 68 %( 16, 17). 
A study of 487 patients to determine factors predisposing and complicating ARF in a 
medical ICU in the Netherlands showed that 16% of patients had ARF and 63% of 
ARF patients required RRT. Factors such as advanced age, prior chronic disease, 
cardiovascular and pulmonary failure were independently associated with the 
development of ARF and all these factors together with RRT (except prior chronic 
disease) independently influenced the ARF mortality. The overall mortality in these 
patients was 63%. (15). 
A study form the Western Cape, South Africa, which included a total of 198 medical 
patients admitted to a Medical ICU, reports that 23.2% of patients had or developed 
ARF. The leading causes noted in this study were acute tubular necrosis (82%) 
which resulted from sepsis, hypoperfusion and nephrotoxic medications. Other 
factors attributed to development of ARF included acute glomerulonephritis, 
malignant hypertension and vasculitis. Seventeen percent of patients with ARF 
needed acute renal replacement therapy. Mortality was higher in ARF patients 
(47.8%) compared with 17.5% of patients without ARF. Mechanical ventilation, 
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dialysis and multiorgan failure were noted to affect the outcome (23). Data from a 
study in Johannesburg, looking at the outcome of ICU patients requiring dialysis 
have also reported overall mortality of 52.5 %( 24). 
A prospective study from Germany which looked at 160 patients to assess the 
outcome of patients with ARF requiring daily as compared with alternate day 
haemodialysis, revealed an overall mortality of 37%. ARF patients who were on daily 
haemodialysis had a lower mortality rate of 28% as compared to the conventional 
(alternate day) haemodialysis group (37%) (22). 
A National survey on the epidemiology and outcome of hospitalised ARF patients 
from the USA showed that ARF was commonly found in older patients, men, and 
black patients upon discharge. It was also common in patients with coexisting 
diseases such as congestive cardiac failure, cancer, chronic lung disease, and HIV 
infection. Among patients with ARF, 7.5% required dialysis. Patients with ARF had 
higher a mortality rate of 21.5% as compared to patients without ARF (2.3%) (28). 
A study from Taiwan demonstrated that the mortality in patients with ARF 
progressively increased with each RIFLE class (RIFLE-R, I and F 63.2%, 69.2%, and 
86.2% respectively). Factors associated with increased mortality in each RIFLE class 
included septic shock, liver cirrhosis and ARDS (29). 
A study from Saudi Arabia showed that 9.0% of ARF patients required RRT, and was 
associated with a mortality of 64% .This study showed that high serum creatinine 
was an independent factor for better outcome while mechanical ventilation was an 
independent factor for worse outcome. It was generally found that the need for RRT 
in ICU was associated with high mortality (30).  The association of high serum 
creatinine with better outcome is attributed to the absence or less co-morbid 
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conditions such as liver disease, decreased muscle mass and aging. These 
conditions are associated with decreased creatinine production and their absence 
may favour better outcome (30, 42). 
Data from Pennsylvania in the USA in a multicentre study involving 1530 ICU 
patients with 254 ARF patients, showed an incidence of ARF of 17%. Eleven percent 
of these patients (ARF) needed dialysis. The mortality was higher in ARF patients 
(23%) as compared with 5% of non ARF patients. Patients with ARF on dialysis had 
a mortality rate of 57% (32).  
Two studies looking at outcome of ARF in critically ill HIV patients from Portugal 
have shown that with and without using RIFLE criteria, 47.4% of the study population 
(97 patients) had some degree of renal dysfunction with an overall mortality of 43.3% 
(34,35). Factors independently associated with increased mortality in HIV patients 
with ARF included, age above 60 years, concomitant hepatitis C, and severity of 
illness (34). Based on  RIFLE criteria, it was found out that in HIV patients with ARF, 
26% of patients were in R class, 19.5% in I class and 54.3% in F Class. RIFLE I and 
F class independently predicted mortality (35). 
Another study from France showed that the mortality in critically ill HIV infected 
patients admitted to ICU declined from 25% in 1996 to 8.6% in 2004 to 2005; this 
decline is attributed to the use of HAART and admission to ICU. Factors identified to 
be associated with increased mortality in these patients in ICU included delayed ICU 
admission, acute renal failure, hepatic cirrhosis, severe sepsis and ICU admission 
for coma (36). 
A multicentre prospective study conducted in Belgium over a 3 year period between 
April 2001 and March 2004 to investigate the outcome of AKI and different treatment 
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options included 316 AKI patients on dialysis. In this study 144 patients were 
randomly assigned to receive intermittent renal replacement therapy (IRRT) and 172 
patients to receive continuous renal replacement therapy (CRRT). There was no 
difference in duration of ICU or hospital stay and the mode of dialysis had no impact 
on outcome in ICU. Patients who were on IRRT had a mortality rate of 62.5% 
compared with 58.8% who received CRRT (43). 
Another multicentre prospective study from Italy done between June 2005 and 
December 2007 to evaluate the dose of RRT and the outcome in patients with ARF, 
included 553 AKI patients on RRT. Three hundred and thirty three patients were on 
CRRT and 87 were on IRRT. This study showed no survival benefit among patients 
on higher dose of RRT (44).  
An observational outcome analysis evaluating Intermittent Haemodialysis (IHD) 
versus CRRT for ARF in ICU from the USA which included 161 patients on RRT (84 
on CCRT and 77 patients on IHD), showed that the RRT modality did not affect the 
likelihood of renal recovery, in-hospital survival, or survival during follow up (45). 
Various studies have revealed that Sustained Low Efficiency Dialysis (SLED) is an 
efficient mode of RRT comparable to Continuous Venovenous Hemofiltration 
(CVVH) and has a cardiovascular tolerability profile in critically ill patients similar to 
CRRT (46). 
1.4. Definition of terms 
• Acute renal failure – As per RIFLE classification 
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• Conservative treatment – Patients who received other modes of ARF 
management, such as intravenous fluid and or furosemide infusion but not 
dialysis. 
• Chronic renal failure – Complete loss of renal function for more than four 
weeks as per RIFLE Classification 
• Multidisciplinary ICU – An Intensive Care Unit to which critically ill medical 
and surgical patients are admitted.    
• Recovery of ARF – Either complete whereby kidney function returns to 
baseline classification within the RIFLE criteria, or partial i.e. a persistent 
change in RIFLE classification but not persistent need for RRT (9) 
• Outcome – Patients Discharged dead or alive from ICU and hospital ( for 
those discharged from ICU to the ward)  
1.5. OBJECTIVES OF THE STUDY 
1.5.1. Broad objective 
The broad objective of the study was to assess the outcome of ARF in patients 
admitted to ICU using the RIFLE classification at CMJAH, January to December 
2008. 
1.5.2. Specific objectives 
The specific objectives of this study were;  
1. To determine the incidence of ARF in patients admitted to the multidisciplinary 
ICU at CMJAH, Johannesburg from January 1st  to December 31st, 2008. 
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2. To determine factors associated with ARF recovery in patients admitted to the 
multidisciplinary ICU at CMJAH, Johannesburg from January 1st to December 
31st, 2008. 
3. To assess the mortality of patients with ARF admitted to the multidisciplinary 
ICU based on RIFLE criteria at CMJAH, Johannesburg from January 1st to 
December 31st, 2008. 
4. To assess the factors that independently predict the mortality of patients with 
ARF admitted to the multidisciplinary ICU based on RIFLE criteria at CMJAH, 
Johannesburg from January 1st to December 31st, 2008. 
5. To assess the factors that predict mortality in patients with ARF discharged 
from ICU to the ward based on RIFLE criteria at CMJAH, Johannesburg from 
January 1st  to December 31st ,2008 
1.6. Research question. 
The primary research question of this study was to investigate whether the RIFLE 
criteria is a useful tool for predicting the outcome of acute renal failure in the 
intensive care unit. 
1.7. Variables 
1.7.1. Outcome variables 
• Mortality in ICU and Hospital (for patients discharged from ICU) 
1.7.2. Explanatory variables 
• Demographic factors such as age, sex, race, 
• Clinical factors such as reason for ICU admission, inotropic support, 
ventilation support, combined ventilation with inotropic support and dialysis 
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• Comorbidities such as diabetes, chronic pulmonary disease, chronic 
cardiovascular disease, connective tissue disease, HIV status, HIV/TB 
coinfection, cancer 
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CHAPTER TWO 
2. Materials and method 
2.1. Study Design. 
This was a retrospective chart review where medical records of patients with acute 
renal failure admitted to the multidisciplinary intensive care unit at CMJAH for a 
period of one year from January 2008 to December 2008 were reviewed. 
2.2. Study site/ area 
This study was conducted in the multidisciplinary ICU at the Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH). CMJAH is an accredited central tertiary 
care academic hospital with 1088 beds serving patients from across the Gauteng 
province and neighbouring provinces. It is estimated to have more than 4000 
professional and support staff offering a full range of specialized services to 
inpatients and outpatients. 
It is located in Parktown and serves as a referral hospital for a number of hospitals in 
its referral chain. 
The hospital is also a major teaching hospital for The University of the 
Witwatersrand, faculty of Health Sciences for undergraduate and post-graduate 
training in all area of health professions (47) 
The multidisciplinary intensive care unit which is mainly run by the Respiratory Unit 
has an average of 1000 admissions a year with 12 ICU beds in ward 576 and 6 to 8 
beds in high care, ward 579, all located in the medical block. 
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2.3. Study population. 
The study reviewed medical records of patients admitted to the multidisciplinary ICU 
at Charlotte Maxeke Johannesburg Academic hospital from January 2008 to 
December 2008 and assessed for eligibility criteria. 
2.4. Inclusion criteria 
The study included medical records of patients with acute renal failure admitted to 
the multidisciplinary intensive care unit at CMJAH year 2008. 
2.5. Exclusion criteria. 
The following patients were excluded from the study 
• All patients with chronic renal failure whether on dialysis or not. 
• Patients admitted with acute on chronic renal failure. 
• Readmitted patients who previously had ARF in ICU (only entered once in the 
data sheet) 
• Patients who were less than 18years of age. 
• Patients with ARF whose outcome data was missing in the record. 
 
2.6. Sampling and sample size  
A total number of 507 patients’ files for the period of one year from January to 
December 2008 were available for review. Thirty seven patients with renal failure 
were excluded from the study (14 – Chronic renal failure, 6 – readmitted, so entered 
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once in the data set, 7 –less than 18 years of age, and 10 patients had no outcome 
indicated on discharge from ICU-missing data).Hence 193 study participants with 
acute renal failure were included in the study as summarised below 
 
 
 
 
  
 
 
 
 
 
 
 
 
Figure 5.Flow diagram of the study population 
 
 
 
507 ICU 
admissions 
230 patients with 
renal failure 
193 Patients 
with ARF 
10 Patients with 
ARF excluded. 
Had no outcome 
indicated on 
discharge 
7 patients less 
than 18 years 
old excluded 
14 patients 
with known 
CRF 
6 patients 
readmitted, 
entered only 
once 
277 patients with normal 
renal function 
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2.7. Data management 
2.7.1. Data collection 
The following data were collected from the patients’ records: demographic 
information, reason for ICU admission, presence of co-morbidity, RIFLE criteria for 
ARF on admission and on discharge, clinical details, modality and duration of 
treatment specifically for acute renal failure, use and duration of inotropic support 
and need for mechanical ventilation and its duration. Data on occupation, level of 
education, social habit such as alcohol intake and smoking were not documented in 
the majority of patients’ files hence not recorded for analysis. For the purpose of this 
study, serum creatinine was used as per RIFLE classification to define ARF.  
The above information was recorded and then entered in Microsoft Excel 2007 
relational database software by the investigator. The data set was then transferred to 
STATA version 11 for; cleaning which involved removal of duplicates and checking 
for missing variables, grouping and coding, determining for internal consistency and 
statistical analysis. 
2.7.2. Data analysis 
The Primary outcome, which was survival or death, was then assessed in relation to 
the maximum RIFLE classification reached during patients’ ICU stay.  
Continuous variables such as age were described by determining their means, 
standard deviations, and ranges and categorical variables were presented in 
frequency distribution tables. The Chi-square test (bivariate analysis) was used to 
compare the proportions patients with acute renal failure or deaths between 
independent variables and chi-square of trend was used for ordered categorical 
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variables such as age and RIFLE criteria. A p value≤0.1 was considered statistically 
significant where the chi-square test was used. 
Variables that were found to be statistically significant in the bivariate analysis were 
then subjected to inferential statistics for univariate and/ or multivariate Cox hazards 
regression model to assess the outcomes and independent effects of the respective 
variables and control for confounding variables. A p-value ≤0.05 was used for 
inferential statistics. Survival analysis was also performed for each significant 
variable from the above regression model. This was presented by using Kaplan-
Meier (K-M) curve and log-rank was used to test for significance. 
2.8. ETHICAL CONSIDERATION 
The study was unconditionally approved by the Human Research ethics committee 
(Medical), University of the Witwatersrand, Clearance certificate number M090906. 
Only serial numbers were used to all patients’ files reviewed in the study to maintain 
confidentiality. 
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CHAPTER THREE 
3. Results 
3.1. Descriptive analysis 
3.1.2. Demographic characteristics of the study participants. 
A retrospective chart review was conducted over a period of one year and a total 
number of 193 patients with ARF were enrolled in the study with a mean APACHE II 
score of 19 ± 6.4 SD, the maximum score documented being 38 (table 3). 
The age of the study participants ranged between 21 and 92 years with a mean age 
of 50.5years ± 18.3 SD. 64.2% of all patients were above 41years of age. 
The majority of patients were male (52.3%) and black (63%) (table 4).  
Table 3.APACHE II score 
Variable Observation     Mean   SD             Min              Max 
APACHE II   193                 19.1     6.4             7                 38 
 
Table 4.Demographic characteristics of Patients with ARF  
 
Variable 
 
Number Percentage (%) 
Age 
  18-40years 
  41-60years 
  > 60years 
 
69 
62 
62 
 
35.8 
32.1 
32.1 
Sex 
  Female 
  Male 
 
92 
101 
 
47.7 
52.3 
Race 
  Black 
  Other race groups 
 
122 
71 
 
63.2 
36.8 
 
 
3.1.3. Comparison of patients by RIFLE criteria. 
The majority of the patients on admission had normal renal function (40.9%) with 
RIFLE R, I and F class constituting 23.3%, 14.0% and 21.8 % respectively (Table 4).  
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Table 5.Distribution of patients based on RIFLE criteria 
Variable Number Percentage (%) 
RIFLE on admission 
  Normal renal function 
  R class 
  I class 
  F class 
 
79 
45 
27 
42 
 
 
40.9 
23.3 
14.0 
21.8 
Maximum RIFLE in ICU  
  Normal renal function 
  R class 
  I class 
  F class 
 
63 
31 
46 
43 
 
34.4 
17.0 
25.1 
23.5 
 
 
3.2. Bivariate analysis 
3.2.1. Comparison of number of organ(s) involved with RIFLE classification 
 
Patients with RIFLE I and F class had two or more organ involvement (Table 5).   
 
Table 6.Comparison of NOI with maximum RIFLE 
 
Variable                        RIFLE Class 
  NRF               R class                I class          F class 
P-value 
NOI 
1 
2 
≥3 
 
28(44.4%) 
25(39.7%) 
10(15.9%) 
 
10(32.3%) 
15 (48.4%) 
6(19.3%) 
 
12(26.1%) 
30(65.2%) 
4(8.7%) 
 
16(37.2%) 
17(39.5%) 
10(23.3%) 
 
 
0.119 
NRF=Normal renal function, NOI= Number of organ(s) involved 
 
3.2.2. Factors associated with acute renal failure recovery in the intensive care 
unit. 
The Chi square test was performed to determine the difference between the 
distributions of factors associated with ARF recovery. A factor was considered for 
multivariate analysis if it had a P-value of ≤ 0.1. Factors associated with ARF 
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recovery were: use of inotropic support, ventilatory support, need for both-ventilatory 
and inotropic support, and the need for dialysis. 
 
Table 7.Comparison of factors on recovery of ARF in ICU 
Variable Recovered ARF 
Number (%) 
ARF 
Number (%) 
P-value 
Age 
  18- 40 years 
  41-60 years 
  >60 years 
 
26 (41.3%) 
16 (25.4%) 
21 (33.3%) 
 
37 (30.8%) 
43 (35.8%) 
40 (33.3%) 
 
 
0.259 
Sex 
  Female 
  Male 
 
31 (49.2%) 
32 (50.8%) 
 
56 (46.7%) 
64 (53.3%) 
 
0.744 
Race 
  Black 
  Other race groups 
 
38 (60.3%) 
25 (39.7% 
 
76 (63.3%) 
44 (36.7%) 
 
0.689 
Reason for admission 
  Cardiovascular disease 
  Gastrointestinal disease 
  Metabolic disease 
  Neurological disease 
  Poisoning 
  Post-surgery 
  Pulmonary disease 
  Sepsis 
 
4   (6.4%) 
2   (3.2%) 
2   (3.2%) 
0   (0) 
1   (1.6%) 
29 (46.0%) 
18 (28.6%) 
7   (11.1%) 
 
10 (8.3%) 
9    (7.5%) 
6    (5.0%) 
4    (3.3%) 
3    (2.5%) 
51 (42.5%) 
25 (20.8%) 
12 (10.0%) 
 
 
 
 
0.625 
Diabetes 
  No 
  Yes 
 
56 (88.9%) 
7 (11.1%) 
 
110 (91.7%) 
10 (8.3%) 
 
0.539 
Chronic pulmonary disease 
  No 
  Yes 
 
51 (81.0%) 
12 (19.0%) 
 
105 (87.5%) 
15 (12.5%) 
 
0.235 
Chronic cardiovascular disease 
  No 
  Yes 
 
38 (60.3%) 
25 (39.7%) 
 
80 (66.7%) 
40 (33.3%) 
 
0.394 
HIV status 
  No 
Yes 
Unknown 
 
37 (58.7%) 
12 (19.1%) 
14 (22.2%) 
 
60 (50.0%) 
33 (27.5%) 
27 (22.5%) 
 
 
0.407 
HIV/TB co infection 
  No 
  Yes 
  Unknown 
 
39 (61.9%) 
4 (6.3%) 
20 (31.8%) 
 
63 (52.5%) 
12 (10.0%) 
45 (37.5%) 
 
 
0.434 
Cancer 
  No 
  Yes 
 
57 (90.5%) 
6 (9.5%) 
 
112 (93.3%) 
8 (6.7%) 
 
0.49 
Connective tissue disease 
  No 
 
62 (98.4%) 
 
115 (95.8%) 
 
0.352 
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  Yes 1 (1.6%) 5 (4.2%) 
Re-operated 
  No  
  Yes 
 
52 (82.5%) 
11(17.5%) 
 
102 (85.7%) 
17 (14.3%) 
 
0.572 
Inotropic support 
  No 
  Yes 
 
25 (39.7%) 
38 (60.3%) 
 
19 (24.0%) 
101 (84.2%) 
 
 
0.00* 
Ventilatory support 
  No 
  Yes 
 
16 (25.4%) 
47 (74.6%) 
 
13   (10.8%) 
107 (89.2%) 
 
 
0.10* 
Ventilatory and inotropic support. 
   No 
  Yes 
 
29 (46.0%) 
34 (54.0%) 
 
24 (20.0%) 
96 (80.0%) 
 
 
0.00* 
Dialysis 
  No 
  Yes 
 
46 (73.0%) 
17 (27.0%) 
 
39 (32.5%) 
81 (67.5%) 
 
 
0.00* 
RIFLE on admission 
Normal 
R class 
I class 
F class 
 
33 (52.4%) 
16 (25.4%) 
9 (14.3%) 
5 (7.9%) 
 
42 (35.0%) 
28 (23.3%) 
17 (14.2%) 
33 (27.5%) 
 
 
0.013* 
RIFLE in ICU 
Normal 
R class 
I class 
F class 
 
20 (32.3%) 
25 (40.3%) 
15 (24.2%) 
2 (3.2%) 
 
9 (8.0%) 
23 (20.4%) 
39 (34.5%) 
42 (37.2%) 
 
 
0.00* 
*Statistically significant 
3.3. Inferential statistics 
3.3.1. Univariate Cox proportional Hazards regression 
Factors with p-value ≤ 0.1 in the bivariate analysis were considered significant hence 
were evaluated further in the univariate Cox Proportional Regression model to 
assess their association with ARF recovery and the P-value 0.05 was considered 
significant. All factors were not statistically significant after univariate cox proportional 
regression analysis (Table 6) 
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Table 8. Factors associated with ARF recovery. 
 Univariate Cox Proportional Hazards regression analysis 
 
Factor           Univariate 
       HR, 95%CI, P-value 
Inotropic Support 
No 
Yes 
 
1 
1.26 (0.77        2.06) 0.36 
Ventilatory support 
No 
Yes 
 
1 
0.79 (0.44        1.42) 0.42  
Ventilatory and inotropic support 
No 
Yes 
 
1 
1.21 (0.77        1.89) 0.41 
Dialysis 
No 
Yes 
 
1 
1.44 (0.98         2.13) 0.06 
NOTE HR =Hazard ratio, CI = Confidence interval 
 
3.4. Mortality in patients with ARF in the intensive care unit 
The Chi square test was performed to determine the distributions of factors 
associated with mortality. A factor was considered statistically significant if it had a P-
value of ≤ 0.1. The overall mortality in patients with ARF was 59.95%.Factors 
significantly associated with mortality were: age, race, Cancer, inotropic support, 
ventilatory support, need for ventilation and inotropic support, dialysis, chronic 
pulmonary disease and maximum RIFLE class in ICU. 
Table 9. Factors associated with mortality in patients with ARF in ICU. 
Variable Alive Dead P-value 
Age 
  18-40years 
  41-60years 
  >60years 
 
35 (44.9%) 
26 (33.3%) 
17 (21.8%) 
 
34 (29.6%) 
36 (31.3%) 
45 (39.1%) 
 
 
0.024* 
Race 
  Black 
  Other race groups 
 
57 (73.1%) 
21 (26.9%) 
 
65 (56.5%) 
50 (43.5%) 
 
0.019* 
Sex 
  Female 
  Male 
 
36 (46.2%) 
42 (53.8%) 
 
56 (48.7%) 
59 (51.3%) 
 
0.729 
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Maximum RIFLE 
  Normal 
  R class 
  I class 
  F class 
 
48 (61.5%) 
9 (11.5%) 
12 (15.4%) 
9 (11.5%) 
 
15 (14.3%) 
22 (21.0%) 
34 (32.4%) 
34 (32.4%) 
 
 
 
0.00* 
Diabetes 
  No 
  Yes 
 
71 (91.0%) 
7 (9.0%) 
 
104 (90.4%) 
11 (9.6%) 
 
0.890 
Chronic cardiovascular disease 
  No 
  Yes 
 
53 (68.0%) 
25 (32.0%) 
 
75 (65.2%) 
40 (34.8%) 
 
0.694 
HIV status 
  No 
  Yes 
  Unknown 
 
39 (50.0%) 
20 (25.6%) 
19 (24.4%) 
 
60 (52.2%) 
29 (25.2%) 
26 (22.6%) 
 
 
0.948 
HIV/TB co infection 
  No 
  Yes 
  Unknown 
 
42 (53.9%) 
5 (6.4%) 
31 (39.7%) 
 
62 (53.9%) 
13 (34.8%) 
40 (11.3%) 
 
 
0.471 
Cancer 
  No 
  Yes 
 
69 (88.5%) 
9 (11.5%) 
 
109 (94.8%) 
6 (2.2%) 
 
 
0.107* 
Connective tissue disease 
  No 
  Yes 
 
76 (97.4%) 
2 (2.6%) 
 
111 (96.5%) 
4 (3.5%) 
 
 
0.720 
Chronic pulmonary disease 
  No 
  Yes 
 
71 (91.0%) 
7 (9.0%) 
 
94 (81.7%) 
21 (18.3%) 
 
0.072 
Inotropic support 
  No 
  Yes 
 
35 (44.9%) 
43 (55.1%) 
 
9 (7.8%) 
106 (92.2%) 
 
 
0.00* 
Ventilatory support 
  No 
  Yes 
 
20 (25.6%) 
58 (74.4%) 
 
9 (7.8%) 
106 (92.2%) 
 
0.001* 
Ventilatory and inotropic support 
  No 
  Yes 
 
39 (50.0%) 
39 (50.0%) 
 
14 (12.2%) 
101 (87.8%) 
 
 
0.00* 
Dialysis 
  No 
  Yes 
 
46 (59.0%) 
32 (41.0%) 
 
44 (38.3%) 
71 (61.7%) 
 
 
0.005* 
*Statistically significant 
 
3.5. Inferential statistics 
3.5.1. Univariate and Multivariate Cox Proportional Hazards regression  
Factors with p-value ≤ 0.1 in the bivariate analysis were considered significant hence 
were evaluated further in the univariate Cox Proportional Regression model to 
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assess independent association with mortality. 
All variables with p-value ≤ 0.05 in the Univariate Cox Proportio nal Regression 
model were considered significant. Race, inotropic support, a need for both-
ventilation with inotropic support and maximum RIFLE criteria were retained in the 
final multivariate Cox Proportional Regression model. After Univariate analysis Race, 
inotropic support, ventilation with inotropic support and maximum RIFLE criteria 
variables were statistically significant. After multivariate analysis race, inotropic 
support, maximum RIFLE class and need for both-ventilation and inotropic support 
remained statistically significant. Non-blacks had 1.56 fold greater risk of dying as 
compared to blacks (adjusted HR 1.56, 95%CI 1.07 - 2.28; p-value 0.02). Those on 
inotropic support had 2.36 fold greater risk of dying as compared to those who were 
not (adjusted HR 2.36, 95%CI 1.02 – 6.18; p-value 0.04). Those who needed both- 
ventilation and inotropic support had 1.14 greater risk of dying as compared to those 
who were not (adjusted HR 1.14, 95%CI 1.09 – 2.53, p-value 0.01). With RIFLE 
criteria, patients in R, I, and F class had 5.41, 3.17, 5.69 greater risk of dying 
respectively as compared to patients with normal renal function (adjusted HR 5.41 
95%CI 2.66 - 11.0, p-Value 0.000 for R class, HR 3.17 95%CI 1.65 - 6.07; p-value 
0.001for I class, and HR 5.69 95%CI 2.93 - 11.06, p-value 0.001 for F class). The 
results are shown in the table below. 
 
Table  10 . Factors associated with mortality. 
Univariate and Multivariate Cox Proportional Hazards Regression results 
 
Factor           Univariate                Multivariate 
       HR, 95%CI, P-value             HR, 95%CI, P-value 
Age Categories 
18 to 40 years 
41 to 60 years 
  
1 
1.07 (0.67      1.72) 0.77 
 
 
 
 31 
> 60 years 1.39 (0.89      2.19) 0.14 
 
Race 
Blacks 
Other race groups 
    
1 
1.63 (1.13       2.39) 0.01 
 
 
1 
1.56 (1.07         2.28) 0.02* 
Inotropic support 
No 
Yes 
 
1 
2.76 (1.39     5.46) 0.004 
 
 
 
1 
2.36 (1.02          6.18) 0.04* 
 
Ventilatory support 
No 
Yes 
 
1 
1.18 (0.59       2.35) 0.64 
 
VS and IS 
No 
Yes 
 
1 
2.17 (1.23     3.79)0 .007 
 
1 
1.14  (1.09           2.53) 0.01* 
Dialysis 
No 
Yes 
 
1 
1.11 (0.76        1.63) 0.59 
 
 
Chronic pulmonary 
disease 
No 
Yes 
 
1 
1.09 (0.67       1.77) 0.73 
 
 
 
 
Maximum RIFLE class 
Normal 
R class 
I class 
F class 
 
1 
5.21 (2.59   10.45) 0.000 
3.63 (1.91     6.89) 0.000 
4.95 (2.59     9.43) 0.000 
 
1 
5.41 (2.66   11.0) 0.000* 
3.17 (1.65   6.07) 0.001* 
5.69 (2.93  11.06) 0.001* 
 
 
 
Assessing proportional hazard assumptions. 
The global test for the proportional hazard assumption of all variables in the 
Univariate and Multivariate model analysis didn’t show evidence that the model 
specified violates proportional hazard assumptions (P-value > 0.05). 
 
Therefore factors independently associated with mortality after multivariate analysis 
were Race (other race groups), Inotropic support, RIFLE class on discharge and a 
need for ventilatory and inotropic support (VS and IS) 
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3.6. Survival analysis 
3.6.1. Incidence 
Patients were at risk for a total of 1268 person days of follow up. The acute renal 
failure incidence rate was 95 /1000 person days.   
By 3rd, 7th and 13th day, ARF had occurred in 25%, 50% and 75% of the study 
participants respectively as shown in figure 6. 
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Figure 6. Kaplan – Meier curve for occurrence of ARF in ICU patients  
 
 
3.6.2. Mortality in ICU 
Patients were at risk for a total of 1268 person days of follow up. The death 
incidence rate was 9/100 person days. Twenty five percent of the patients who died 
survived more than 16 days of follow up. 
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Figure 7. Kaplan – Meier survival curve for ICU patients 
 
3.7. Survival curves for each significant factor after bivariate analysis. 
 
Survival curve by Race 
There is a difference in survival among patients in race categories. Blacks had 
improved survival as compared to other race groups. The log-rank test P-value was 
0.006  
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Figure 8. Kaplan – Meier survival curve for ICU patients by race 
 
Survival curve by inotropic support 
Those not on inotropic support had better survival than those who required inotropic 
support. The log-rank test P-value is 0.001 which is statistically significant. 
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Figure 9. Kaplan – Meier survival curve for ICU patients by inotropic support. 
 
Survival curve by ventilation and inotropic support 
Patients who did not require ventilation and inotropic support had better survival than 
those who needed both supportive measures. The log – rank test P-value is 0.004 
which is statistically significant. 
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Figure 10. Kaplan – Meier survival curve for ICU patients by ventilation and 
inotropic support. 
 
Survival curve by maximum RIFLE class 
From the graph, patients with normal renal function have better survival than those 
with ARF based on RIFLE criteria. The log-rank test p-value is 0.000  
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Figure 11. Kaplan – Meier survival curve for ICU patients by maximum RIFLE 
criteria  
3.8. Race 
Overall the majority of the study participants were young and black with less co-
mordities as compared to other race groups. HIV and or coinfection with TB was 
predominantly found in those of black race 
Table 11.Comparison of factors with Race 
Variable Black Other race 
groups 
P-Value 
Age 
18-40 
41-60 
≥61  
  
60 (49.2%)       
39(32.0%) 
23 (18.9%)        
 
9 (12.7%)  
23 (32.4%)   
39(54.9%)           
 
 
0.000* 
Chronic cardiovascular disease 
No  
 
96(78.7%) 
 
31(43.7%) 
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Yes 26(21.3%) 40(56.3%) 0.000* 
Chronic pulmonary disease 
No 
Yes   
 
113(92.6%) 
9(7.0%) 
 
53(74.6%) 
18(25.4%) 
 
 
0.000* 
HIV status 
Negative 
Positive 
Unknown 
 
47(38.5%) 
46(37.7%) 
29(23.8%) 
 
52(73.2%) 
3(4.2%) 
16(22.6%) 
 
 
0.000* 
HIV/TB coinfection 
No 
Yes 
Unknown 
 
52(42.6%) 
17(13.9%) 
53(43.5%) 
 
52(73.2%) 
1(1.4%) 
18(25.4%) 
 
 
0.000* 
Cancer 
No 
Yes 
 
116(95.1%) 
6(4.9%) 
 
62(87.3%) 
9(12.7%) 
 
0.031* 
Connective tissue disease 
No 
Yes 
 
120(98.4%) 
2(1.6%) 
 
68(95.8%) 
4(4.2%) 
 
0.133 
 
Number of organ involved 
1 
2 
≥3 
 
42(34.4%)       
59(48.4%) 
21(17.2%) 
 
28(39.4%) 
34(47.9%) 
9(12.7%) 
 
 
0.588 
*Statistically significant 
 
In summary the results from this study in ICU have shown that in the bivariate 
analysis, multiple factors are associated with mortality in ICU. Factors such as race 
(other race groups), need for inotropic support, need for both –ventilation and 
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inotropic support, and maximum RIFLE criteria reached are independently 
associated with high mortality. 
 
3.9.0 MORTALITY IN HOSPITAL 
3.9.1. Bivariate analysis 
3.9.2. Overall mortality 
Total number of patients discharged to the ward from ICU was 78 patients, with the 
overall hospital mortality of 14.1% (11 patients died 14.1%, and 67 patients alive 
85.9%). 
The Chi square test was performed to determine the distributions of factors 
associated with mortality. Factors which were statistically significant after bivariate 
analysis (P-value ≤0.1) were sex, maximum RIFLE class, cancer, connective tissue 
disease, need for both-ventilation and inotropic support and conservative treatment 
as shown in the table below. 
Table 12.Factors associated with mortality in patients with ARF in Hospital. 
Variable Alive Dead P-value 
Age 
  18-40years 
  41-60years 
  >60years 
 
31 (46.3%) 
23 (34.3%) 
13 (19.4%) 
 
4(36.4%) 
3(27.3%) 
4 (36.4%) 
 
 
0.450 
Race 
  Black 
  Other race groups 
 
49 (73.1%) 
18 (26.9%) 
 
8 (72.7%) 
3 (27.3%) 
 
0.977 
Sex 
  Female 
  Male 
 
28 (41.8%) 
39 (58.2%) 
 
8 (72.7%) 
3 (27.3%) 
 
 
0.056* 
Reason for admission 
  Cardiovascular disease 
  Gastrointestinal disease 
  Metabolic disease 
  Poisoning 
 
3 (4.5%) 
3 (4.5%) 
5 (7.5%) 
1 (1.5%) 
 
1 (9.1%) 
0 (0.0%) 
0 (0.0%) 
0 (0.0%) 
 
 
 
 
0.751 
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  Post-surgery 
  Pulmonary disease 
  Sepsis 
32 (47.5%) 
18 (26.9%) 
5 (7.5%) 
6 (54.6%) 
2 (18.2%) 
2 (18.2%) 
Maximum RIFLE criteria 
  Normal 
  R class 
  I class 
  F class 
 
43 (%) 
9 (13.0%) 
10 (14.9%) 
5 (7.5%) 
 
5 (45.5%) 
0 (0.00%) 
2 (18.1%) 
4 (36.4%) 
 
 
 
0.031* 
Diabetes 
  No 
  Yes 
 
62 (92.5%) 
5 (7.5%) 
 
9 (81.8%) 
2 (18.2%) 
 
0.249 
Chronic cardiovascular disease 
  No 
  Yes 
 
47 (70.2%) 
20 (29.8%) 
 
6 (54.5%) 
5 (45.5%) 
 
0.030* 
HIV status 
  No 
  Yes 
  Unknown 
 
34 (50.8%) 
18 (26.9%) 
15 (22.4%) 
 
5 (45.5%) 
2 (18.2%) 
4 (36.4%) 
 
 
0.580 
HIV/TB co infection 
  No 
  Yes 
  Unknown 
 
37 (55.2%) 
4 (6.0%) 
26 (38.8%) 
 
5 (45.5%) 
1 (9.0%) 
5 (45.5%) 
 
 
0.812 
Cancer 
  No 
  Yes 
 
61(91.0%) 
6 (9.0%) 
 
8 (72.7%) 
3 (27.3%) 
 
0.078* 
Connective tissue disease 
  No 
  Yes 
 
67 (100%) 
0 (0.0%) 
 
9 (81.8%) 
2 (18.2%) 
 
0.00* 
 
Chronic pulmonary disease 
  No 
  Yes 
 
61 (91.0%) 
6 (9.0%) 
 
10 (90.9%) 
1 (9.1) 
 
0.988 
Inotropic support 
  No 
  Yes 
 
32 (47.8%) 
35 (52.2%) 
 
3 (27.3%) 
8 (72.7%) 
 
0.205 
Ventilatory support 
  No 
  Yes 
 
19 (28.4%) 
48 (71.6%) 
 
1 (9.1%) 
10 (90.9%) 
 
0.175 
Ventilatory and inotropic support 
  No 
  Yes 
 
37 (55.2%) 
30 (44.8%) 
 
2 (18.2%) 
9 (81.8%) 
 
0.023* 
Conservative treatment 
  IVF 
  IVF and Lasix infusion 
  No 
 
50 (74.6%) 
15 (22.4%) 
2 (3.0%) 
 
5 (45.5%) 
6 (54.5%) 
0 (0.0) 
 
 
0.078* 
Dialysis 
  No 
  Yes 
 
41 (61.2%) 
26 (38.8%) 
 
5 (45.5%) 
6 (54.5%) 
 
0.325 
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3.9.3. Inferential statistic 
3.9.4. Univariate Cox Proportional Hazards Regression 
Statistically significant factors qualified for inferential statistics by Cox proportional 
hazard regression. The significant criteria here is taken as a p-value ≤0.05. Those 
who had cancer were 7.48 fold more at risk of hospital death as compared to those 
who had no cancer, summarised in the table below. 
Table 13. Factors associated with hospital mortality.  
Factor           Univariate 
       HR, 95%CI, P-value 
Sex 
Female 
Male 
  
1 
0.29 (0.07       1.16) 0.08 
 
Cancer 
No 
Yes 
 
1 
7.48 (1.48      37.77) 0.015 
    
 
Connective tissue disease 
 
No 
Yes 
 
 
1 
2.28 (0.42        12.32) 0.338 
 
 
Conservative treatment 
 
No 
Yes 
 
 
1 
0.68 (0.59         2.35) 0.64 
VS and IS 
 
No 
Yes 
 
 
1 
1.78 (0.34         9.22) 0.49 
RIFLE on hospital discharge 
Normal 
R 
I 
F 
 
1 
5.89 (0.79          2.69) 1.00 
2.13 (0.37        12.13) 0.39 
1.25 (0.29          5.28) 0.76 
 
NOTE: Cancer is the only significant factor after Univariate analysis (Adjusted 
HR 7.48, 95%CI 1.48 – 37.77, p-value 0.015).No need for multivariate model 
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3.9.5. Survival analysis 
Patients were at risk for a total of 1398 person days. Death incidence rate was 
0.0078.By the 55th day of follow up, 75% of patients had already died. 
Survival curves. 
Twenty five percent of patients who died in hospital survived for more than 55 days 
of follow up.  
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Figure 12. Kaplan – Meier curve for hospital patients mortality 
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Survival curve by Sex 
From the graph males seem to have improved survival as compared to the females. 
The log-rank test P-value is 0.06 which is not statistically significant. However, a 
trend is noted. 
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Figure 13. Kaplan – Meier survival curve for hospital patients by sex. 
 
Survival curve by Cancer 
Those with no cancer have improved survival as compared to those with Cancer. 
The log-rank test p-value is 0.004 which is statistically significant. 
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Figure 14. Kaplan – Meier survival curve for hospital patients by cancer 
 
The results from hospital patients in this study show that despite the fact that multiple 
factors are associated with mortality in patients with ARF in hospital in the bivariate 
analysis, univariate Cox hazards regression analysis reveals cancer to be the only 
factor that is independently associated with mortality. 
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CHAPTER 4: DISCUSSION 
4.0. Discussion  
This was a retrospective chart review that aimed at assessing the outcome of 
patients with Acute Renal Failure (ARF) in the Intensive Care Unit (ICU). We 
screened a total number of 507 patients admitted in ICU, and according to RIFLE 
criteria, 193 patients with ARF were included in the study. This accounted for 38.1 
%( 193/507) of all patients who were admitted to ICU during the study period. This 
incidence is similar to that reported in other studies (11, 18, 25, 26). Of those 
patients with ARF on admission 40.9% (79 patients), had normal renal function, 
23.3% (45 patients), 14% (27 patients), and 21% (42 patients) were in R class, I 
class, and F class respectively with maximum RIFLE class during ICU stay was 
17%, 27%, and 23% for R, I, and F class respectively. The range of maximum RIFLE 
class observed in this study is consistent with that published in other studies (8, 26). 
In this study dialysis was initiated in 53.4% (103/193) of all patients with ARF.   
The mean age of the study population was 50.5 ± 18 years, with the majority of 
patients being in the age group of 18 years to 40years. The majority of the patients 
were black (63.2%). This may be explained by the demographics in South Africa 
(48). The mean age in the present study was similar to that previously reported (24, 
41) and was younger than that found in other study (56). This may be explained by 
the predominance of young age group found in this study.  
With regard to predisposing factors for ARF in ICU, neither demographic 
characteristics such as age, race and sex, reason for admission, nor comorbidity 
present in this study were associated with ARF. This is in contrast to the data 
reported from other studies (15, 18, 28). The possible reasons for this include the 
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fact that majority of patients were relatively young, had two or less organ 
involvement on admission and throughout the ICU stay, and that  the number of 
patients with co-morbidity and normal renal function on admission, were insignificant 
to show statistical association with the development of ARF. The recovery rate in the 
present study was 34.5% which was consistent to other reported data (16).  
In this study, the overall mortality rate in patients with ARF was found to be 
59.9%.This finding is similar to that found in other studies performed in Brazil, Saudi 
Arabia and the United Kingdom (25, 30, 49). It is however, slightly higher than that 
previously reported in South Africa (23, 24). In the bivariate analysis, we found that 
factors such as age, race, inotropic support, ventilatory support, need for both - 
ventilatory and inotropic support, dialysis, chronic pulmonary disease and maximum 
RIFLE class in ICU were significantly associated with mortality. With the exception of 
the need for both – ventilatory and inotropic support, the influences of other factors 
on the mortality in this study have also been reported in other studies (12, 14, 15, 26, 
30). Factors such as race, inotropic support, maximum RIFLE class and need for 
both (ventilation and inotropic support) were subjected to multivariate regression 
analysis after remaining statistically significant in the univariate analysis which 
revealed that when present, they are independently associated with mortality. This is 
in accordance with data from other studies (25). 
 With RIFLE criteria, patients in R, I, and F class had more than 3 fold  risk of dying 
as compared to patients with normal renal function (adjusted HR 5.41 95%CI 2.66 - 
11.0; p-value 0.000 for R class, HR 3.17 95%CI 1.65 - 6.07; p-value 0.001 for I class, 
and HR 5.69 95%CI 2.93 - 11.06; p-value 0.001 for F class).This correlation and 
predictive ability of maximum RIFLE criteria in critically ill ARF patients with respect 
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to mortality is consistent with results found in other studies (29, 35, 49). This finding 
adds to the paucity of information from African facilities.  
It was found in this study that other race groups had 1.56 fold greater risk of dying 
compared to blacks (adjusted HR 1.56, 95%CI 1.07 - 2.28, p-value 0.02). This 
observation has previously been published and although the reason for this finding is 
not clear, it may partly be explained by more comorbid conditions in non-black 
patients (other race groups), young age in black patients as compared with their 
counterparts, and possible biological differences between the two groups (40). 
The currently available evidence supports the fact that the use of inotropic support in 
critically ill patients with ARF is independently associated with mortality (14, 25). In 
this study we found that patients with ARF on inotropic support had 2.36 fold greater 
risk of dying as compared to those who were not (adjusted HR 2.36, 95%CI 1.02 – 
6.18; p-value 0.04).  
This study further demonstrated that those who needed both ventilatory and inotropic 
support had a 1.14 greater risk of dying as compared to those who were not 
(adjusted HR 1.14,95%CI 1.09 – 2.53; p-value 0.01). This finding has mainly been 
reported in paediatric oncology patients where the mortality rate among patients on 
ventilation and those on combined ventilation with inotropic support was 39% and 
65% respectively (50). The above finding may be explained by the fact that patients 
who need inotropic support, ventilation or both are usually extremely ill, often with 
multiple organ failure and hence poorer outcome. The result that mechanical 
ventilation is associated with high mortality is consistent with other published data 
(12, 23, 25, 30, 41). 
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We found that the majority of patients discharged from ICU to the ward survived - 
85.9% discharged alive versus 14.1% who died. Amongst those who died, 25% 
demised after 55 days of follow up in the hospital. In the bivariate analysis, we found 
that factors associated with mortality in the ward were sex, maximum RIFLE class, 
cancer, connective tissue disease, need for both-ventilatory and inotropic support 
and conservative treatments of ARF (Intravenous fluid and or furosemide infusion). 
However, after univariate analysis only cancer showed independent association with 
mortality. This is consistent with previous published data in which patients with 
malignancy were shown to have higher in-hospital mortality and lower survival (51, 
52). We found in the survival analysis that males had improved survival as compared 
with females (Figure 12) although the log-rank test (p-value 0.06) was not statistically 
significant. This finding is in contrast to other studies that have reported male gender 
as a predictive factor of in-hospital mortality (53, 54). Furthermore Mitter N et.al; 
showed no mortality difference between the gender of patients with post-operative 
renal injury (55).The reason for this observation is not clear, but one of the possible 
explanations is the difference in testosterone levels. Of interest, a study by Kyriazis J 
et.al; demonstrated that testosterone deficiency in male haemodialysis patients was 
associated with all-cause mortality (57).  
4.1. Limitations 
This study had several limitations which include 
• It is a single centre study so the results may not be representative of all 
university affiliated ICU’s. 
• Relatively low number of study participants 
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• It is a retrospective study 
4.2. Strength of the study. 
Despite the above limitations, the study; 
• Has contributed data and information on the use of RIFLE criteria and its 
predictive ability for the mortality in an African ICU. 
• Findings on the association of risk factors with mortality were consistent with 
previous studies. 
4.3. Conclusion 
This study found that according to RIFLE criteria, the overall occurrence rate of ARF 
was 38.1% (193/507) in ICU and that each maximum RIFLE class reached 
demonstrated its predictive ability of the outcome in terms of mortality and lower 
survival among patients with ARF in ICU. We have further added information on the 
usefulness of RIFLE criteria from an African institution where there is paucity of data 
regarding its use in predicting outcomes in patients with ARF.  
4.4. Recommendations 
Given the findings from this study, we recommend;   
• The routine use of RIFLE criteria, which is a useful tool for early detection and 
improvement of outcome in critically ill patients with ARF. 
• Further studies regarding various factors that influence the favourable 
outcome among black patients compared to other race groups.  
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Case report form for capturing data from the files 
1. Serial number----- 
2. Demographic information 
i. Age ------------------    
ii. Sex  Female/ Male    M/F 
3. Race i. Other race groups    Yes/No 
ii. Black       Yes/No 
4. Reason for ICU admission 
 i. Sepsis       Yes/No 
ii. Pulmonary disease     Yes/No 
iii. Post-surgery      Yes/No 
iv. Cardiovascular disease    Yes/No 
iv. Gastrointestinal disease    Yes/No 
v. Neurological disease     Yes/No 
vi. Poisoning/overdose     Yes/No 
vii. Metabolic disease Yes/No 
5. Number of organ(s) involved 
 i. One system      Yes/No 
 ii. Two systems      Yes/No 
 iii. Three or more systems     Yes/No  
 
6. Patients’ habit 
I. Alcohol      Yes/No 
ii. Smoking      Yes/No 
iii. Substance abuse    Yes/No 
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7. Comorbidity  
i. Diabetes mellitus     Yes/No 
ii. Chronic cardiovascular disease   Yes/No 
iii. Chronic pulmonary disease   Yes/No 
iv. HIV status      Yes/No/unknown 
V. HIV/TB co infection    Yes/No/Unknown 
V. Cancer      Yes/No 
vi. Connective tissue disease   Yes/No   
v. Reoperation 
8. RIFLE class (based on the increase in serum Creatinine) 
 i. RIFLE on admission 
 ii. RIFLE in ICU 
 iii. RIFLE on discharge 
9: Treatment modality 
 A: Conservative treatment i. Intravenous fluid 
ii. Intravenous fluid and diuretics 
  iii. Duration of conservative treatment-- 
 B: Dialysis 
A. Type of dialysis  
i. Haemodialysis (HD) 
                       ii. Sustained Low Efficiency Dialysis (SLED) 
                       iii. Continuous Veno-Venous Haemodialysis(CVVHD) 
B. Duration of dialysis ------ 
10: Duration of Inotropic support— 
11: Duration of ventilatory support--. 
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12. Ventilatory and inotropic support      Yes/No 
13. Duration of combined ventilation with inotropic support   
14. Duration of stay 1. ICU ---- 
   2. Hospital (discharged patients from ICU to the ward) --- 
12: Outcome -discharged from 
 i. ICU 0: Dead 
  1:  Alive 
ii. Hospital 0: Dead 
   1:  Alive  
   
 
 
 
 
 
 
 
